Disease, Hodgkin
Showing 1 - 9 of 9
Disease, Hodgkin Trial in Worldwide (brentuximab vedotin, )
Completed
- Disease, Hodgkin
- brentuximab vedotin
- placebo
-
Duarte, California
- +86 more
Apr 22, 2021
Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)
No longer available
- Disease, Hodgkin
- +3 more
- brentuximab vedotin
-
Stanford, California
- +30 more
Sep 17, 2020
Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)
Completed
- Disease, Hodgkin
- +2 more
- brentuximab vedotin
-
Birmingham, Alabama
- +16 more
Dec 7, 2016
Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (brentuximab vedotin, rifampin, midazolam)
Completed
- Carcinomas
- +4 more
- brentuximab vedotin
- +3 more
-
Duarte, California
- +5 more
Dec 17, 2014
Disease, Hodgkin Trial in Canada, United States (brentuximab vedotin, doxorubicin, vinblastine)
Completed
- Disease, Hodgkin
- brentuximab vedotin
- +4 more
-
Rochester, Minnesota
- +3 more
Dec 17, 2014
Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Germany, United States (brentuximab vedotin)
Completed
- Disease, Hodgkin
- +2 more
- brentuximab vedotin
-
Birmingham, Alabama
- +8 more
Dec 11, 2014